Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
X.Q. Yan, Ming Ye, Q. Zou, Peng Chen, Z.S. He, Bin Wu and 24 more
- Rank
- 36 of 3,639
- Percentile
- top 1%
- Where
- Annals of Oncology, 2023
- Citations
- 86
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.